These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 10861113)

  • 21. Various scoring systems evaluating histologic features of chronic hepatitis C treated with interferon.
    Ikawa H; Hayashi Y; Ninomiya T; Yano Y; Nakaji M; Nagano H; Seo Y; Kumon Y; Yoon S; Kasuga M; Itoh H; Ohbayashi C
    Hum Pathol; 2001 Sep; 32(9):910-7. PubMed ID: 11567219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model.
    Forns X; Ampurdanès S; Llovet JM; Aponte J; Quintó L; Martínez-Bauer E; Bruguera M; Sánchez-Tapias JM; Rodés J
    Hepatology; 2002 Oct; 36(4 Pt 1):986-92. PubMed ID: 12297848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of intercellular adhesion molecule-1 and nitric oxide in patients with chronic hepatitis related to hepatitis C virus: connection fibrosis.
    Pata C; Yazar A; Altintas E; Polat G; Aydin O; Tiftik N; Konca K
    Hepatogastroenterology; 2003; 50(51):794-7. PubMed ID: 12828087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C.
    Yano M; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Shiono Y; Arao M; Ukai K; Ito H; Watanabe K; Yoshioka K
    Am J Gastroenterol; 2002 Jan; 97(1):133-7. PubMed ID: 11808937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender and liver fibrosis in chronic hepatitis: the role of iron status.
    Rigamonti C; Andorno S; Maduli E; Capelli F; Boldorini R; Sartori M
    Aliment Pharmacol Ther; 2005 Jun; 21(12):1445-51. PubMed ID: 15948811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation.
    Rigamonti C; Donato MF; Fraquelli M; Agnelli F; Ronchi G; Casazza G; Rossi G; Colombo M
    Gut; 2008 Jun; 57(6):821-7. PubMed ID: 18218676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of fibrosis progression in untreated irish women with chronic hepatitis C contracted from immunoglobulin anti-D.
    Levine RA; Sanderson SO; Ploutz-Snyder R; Murray F; Kay E; Hegarty J; Nolan N; Kelleher D; McDonald G; O'Keane JC; Crowe J
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1271-7. PubMed ID: 16901770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C.
    Yadav D; Hertan HI; Schweitzer P; Norkus EP; Pitchumoni CS
    Am J Gastroenterol; 2002 Oct; 97(10):2634-9. PubMed ID: 12385452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Size or the number of portal tracts: which matters in a liver biopsy core in chronic hepatitis C?
    Parkash O; Mumtaz K; Ahmed Z; Hamid S; Jafri F; Jafri W
    J Coll Physicians Surg Pak; 2011 Feb; 21(2):121-2. PubMed ID: 21333250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Medicinal herbs for hepatitis C virus infection.
    Liu JP; Manheimer E; Tsutani K; Gluud C
    Cochrane Database Syst Rev; 2001; 2001(4):CD003183. PubMed ID: 11687177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathological study of the therapeutic effect of compound qinggan granula on chronic hepatitis C].
    Wang L; Ren J; Wang T
    Zhonghua Gan Zang Bing Za Zhi; 2000 Apr; 8(2):91-3. PubMed ID: 10861113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection.
    Regev A; Berho M; Jeffers LJ; Milikowski C; Molina EG; Pyrsopoulos NT; Feng ZZ; Reddy KR; Schiff ER
    Am J Gastroenterol; 2002 Oct; 97(10):2614-8. PubMed ID: 12385448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Relationships between liver function test, serum HBeAg or HBV DNA level and liver pathological changes in patients with chronic hepatitis B].
    Xu QH; Shu X; Chen LB; Huang HH; Zhang K; Li G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):422-4. PubMed ID: 19544633
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis].
    Rao HY; Li J; Zhang LF; Chen HY; Zhu LM; Wei L; Sun Y; Wang H
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):96-100. PubMed ID: 18353212
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.